CD19 and systemic lupus erythematosus: Notably, we report that SLE patients’ peripheral blood is enriched in CD19– PCs, suggesting that the presence of an established pool of CD19– PCs might compromise the efficacy of treatment targeting CD19, such as in CD19-directed chimeric antigen receptor (CAR)-T cells.